The global qPCR Instruments Market size is expected to reach USD 1.39 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.4% from 2021 to 2028. The market is driven by the introduction of novel advanced products and an increase in demand for highly efficient diagnostic equipment.
The demand for qPCR instruments and consumables is
being driven by the spike in the incidence of SARS-CoV-2 infections globally. The
rise in the incidence is expected to add to the number of preventive
screenings. This can be attributed to the fact that nations cannot determine
the number of COVID-19 patients without screening them.
The miniaturization of three basic molecular assays is
expected to increase the accuracy and specificity of diagnostic outcomes, and
hence, increase the demand for molecular diagnostic products. These
improvements are expected to improve the availability of POC molecular
diagnostic tests to yield quick and effective test results. For instance, the
Mic qPCR system by Biomolecular Systems weighs only 2 kilograms, making the
device highly portable and easy to handle.
Newly launched products such as QuantStudio 5 Dx
Real-Time PCR System provide consumers with improved workflows and high-volume
testing to provide faster results. Cost-effectiveness and software that are
simplified give it additional advantages. Furthermore, the approval of the
instrument in over 50 countries can help strengthen the market growth. The
instrument is also equipped with measures for research companion diagnostics,
giving it a competitive edge.
The market has a high threat of external substitutes
owing to the presence of digital PCR instruments that are highly advanced and
more accurate. The strong threat of internal substitution can be attributed to
the presence of numerous products available in the market. However, the higher
price of these instruments is anticipated to reduce the overall threat, keeping
it at a moderate level.
COVID-19 has increased opportunities for diagnostic
devices. However, advanced PCR technologies, such as dPCR, are preferred more
in developed economies as they can help reduce false-positive rates. The
research on developing efficient qPCR instruments can reduce the threat of
substitution of devices and improve market growth.
Over recent years, PCR has witnessed technological
advancements in terms of sensitivity, accuracy, efficiency, and
cost-effectiveness. Key players are introducing novel technologies to maintain
a competitive edge.
Related Press Release@ qPCR Instruments Market Report
qPCR Instruments Market Report
Highlights
- By instrument, the GeneXpert segment is expected to exhibit the
fastest CAGR from 2021 to 2028
- Asia Pacific is expected to witness the fastest growth over the
forecast period due to the increasing number of investments aimed at
improving diagnostic infrastructure and the growing prevalence of
infectious diseases
- Unmet needs in the market are high. For instance, the lack of
affordable qPCR instruments is keeping the market from reaching its full
potential
- Newly launched products such as QuantStudio 5 Dx Real-Time PCR
System provide consumers with improved workflows and high-volume testing
to provide faster results. Cost-effectiveness and software that are
simplified give it additional advantages
- North America captured the largest revenue share in 2020 and is
expected to maintain its lead over the forecast period. Improving
regulatory support and increasing launches of novel products are
anticipated to fuel the market growth
About Us:
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment